Trial intelligence / Profile preview

Comparison of NCX 701 and acetaminophen on endotoxin-induced inflammation in healthy volunteers

ISRCTN13358268Phase 3Completed

Sponsor
Medical University of Vienna
Start
Aug 2002
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of nitroparacetamol and acetaminophen (4 arms), sponsored by Medical University of Vienna. Primary endpoints: Interleukin-6, Interleukin-8 and 4 more. Started Aug 2002; status: completed.

02

Drugs

nitroparacetamolacetaminophen

Beyond the preview

Go deeper on ISRCTN13358268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN13358268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call